Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Author:

Crippa José Alexandre S.12ORCID,Pacheco Julia Cozar1,Zuardi Antonio W.12,Guimarães Francisco S.23,Campos Alline Cristina3,Osório Flávia de Lima12,Loureiro Sonia Regina1,dos Santos Rafael G.12,Souza José Diogo S.1,Ushirohira Juliana Mayumi1,Ferreira Rafael Rinaldi3,Mancini Costa Karla Cristinne3,Scomparin Davi Silveira3,Scarante Franciele Franco3,Pires-Dos-Santos Isabela3,Mechoulam Raphael4,Kapczinski Flávio256,Fonseca Benedito A.L.7,Esposito Danillo L.A.7,Passos Afonso Dinis Costa8,Dal Fabbro Amaury Lelis8,Bellissimo-Rodrigues Fernando8,Arruda Eurico9,Scarpelini Sandro10,Andraus Maristela Haddad11,Nather Junior Julio Cesar12,Wada Danilo Tadao12,Koenigkam-Santos Marcel12,Santos Antonio Carlos12,Busatto Filho Geraldo13,Hallak Jaime E.C.12,

Affiliation:

1. Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

2. National Institute for Science and Technology—Translational Medicine, São Paulo, Brazil.

3. Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

4. Department of Medicinal Chemistry and Natural Products, The Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.

5. Department of Psychiatry and Behavioural Neurosciences, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada.

6. Graduate Program in Psychiatry and Behavioral Sciences, Department of Psychiatry, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

7. Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

8. Department of Social Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

9. Department of Cell and Molecular Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

10. Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

11. Chromatox Laboratory Ltda., São Paulo, Brazil.

12. Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

13. Laboratory of Psychiatric Neuroimaging (LIM 21), Department of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3